INTRODUCTION {#S1}
============

Multicellular organisms have evolved diverse strategies to maintain mitochondrial homeostasis in response to environmental and endogenous stress imposed by changes in their surroundings. The nervous system is emerging as a critical coordinator of organism-wide protection that regulates stress response pathway activation in distal tissues through the release of neuroendocrine signals ([@R4]; [@R9]; [@R26]; [@R43]; [@R51]). However, little is known about the molecular mechanisms by which signals from the nervous system are perceived by distal tissues to regulate stress responses.

The mitochondrial unfolded protein response (UPR^mt^) is an evolutionarily conserved adaptive response that functions to maintain mitochondrial protein homeostasis in response to mitochondrial dysfunction caused by mitochondrial DNA damage, impaired mitochondrial protein folding, or perturbations in oxidative phosphorylation. Defects in the UPR^mt^ are implicated in the development of numerous diseases, neurodegeneration, and aging ([@R9]; [@R24]; [@R25]; [@R36]). UPR^mt^ is initiated when the activation of signaling pathways originating in mitochondria leads to epigenetic modifications and transcriptional responses in the nucleus that restore mitochondrial homeostasis. Genetic screens in Caenorhabditis *elegans* have identified several components of the UPR^mt^, including the leucine zipper transcription factor ATFS-1, a critical activator of the UPR^mt^. Under normal conditions, ATFS-1 is imported into mitochondria, where it is degraded by the Lon protease. Upon mitochondrial stress, mitochondrial protein import is compromised, and ATFS-1 translocates into the nucleus, where it regulates the expression of a cascade of genes, including the mitochondrial chaperones HSP-6 and HSP-60 ([@R32]). A second transcription factor, DVE-1, functions with the nuclear protein LIN-65 and the chromatin remolding protein MET-2 to enhance ATFS-1mediated activation of the UPR^mt^ ([@R53]). Early signaling events in mitochondria that lead to UPR^mt^ activation include the recognition and degradation of misfolded or unassembled mitochondrial matrix proteins by the quality control protease CLPP-1/ClpP into peptide fragments, which are subsequently exported into the cytoplasm through the ABC transporter HAF-1, where they may inhibit mitochondrial protein import ([@R15]; [@R31]). Besides CLPP-1-mediated proteolysis, protein prenylation by the mevalonate pathway and the generation of the sphingolipid ceramide on mitochondrial membranes define additional critical events in the activation of the UPR^mt^ ([@R24]).

The UPR^mt^ can be activated either cell autonomously by mitochondrial stress or cell non-autonomously through the release of diffusible factors from neighboring or distant cells ([@R4]; [@R9]; [@R43]). In C. elegans, multiple forms of mitochondrial dysfunction in the nervous system activate the UPR^mt^ in the intestine through the release of specific neuropeptide-like proteins or serotonin from sensory neurons and/or interneurons ([@R4]; [@R43]). Because increasing or decreasing the strength of signaling by these factors can promote (increasing) or block (decreasing) stress-induced UPR^mt^ activation, the coordination of neuroendocrine signaling by the nervous system is likely to play a critical role in the organism-wide adaptive response to mitochondrial stress. Neuroendocrine-mediated activation of the UPR^mt^ in the intestine requires ATFS-1, but the roles of the other components are less clear, and how neuroendocrine signals lead to activation of the UPR^mt^ in the intestine is not known.

In this study, we identify a function for the sole *C*. *elegans* sphingosine kinase ortholog SPHK-1, which catalyzes the conversion of sphingosine (SPH) to sphingosine-1-phosphate (S1P) in the activation of the UPR^mt^. We find that *sphk-1* knockout blocks UPR^mt^ activation induced by diverse mitochondria stressors, whereas SPHK-1 overexpression activates the UPR^mt^. We find that SPHK-1 is targeted to mitochondria in the intestine in response to stress before the induction of the UPR^mt^, and mitochondrial SPHK-1 targeting is required for UPR^mt^ activation. SPHK-1 mitochondrial abundance is positively regulated by neuroendocrine signaling, and *sphk-1* is required for UPR^mt^ activation elicited by mitochondrial stress originating from the nervous system. Our results indicate that SPHK-1 functions as an early mitochondrial signal to activate the UPR^mt^ in response to both cell autonomous and cell non-autonomous stresses. We propose that SPHK-1::GFP fusion proteins may be useful biomarkers for monitoring early signaling events in mitochondria during UPR^mt^ activation *in vivo*.

RESULTS {#S2}
=======

SPHK-1 Functions Cell Autonomously in the Intestine to Selectively Activate the UPR^mt^ {#S3}
---------------------------------------------------------------------------------------

A prior genetic study found that knockdown of *sptl-1* serine palmitoyltransferase, which functions in a key step in the biosynthesis of sphingolipids, blocks UPR^mt^ activation. The defect in UPR^mt^ activation was attributed to the depletion of mitochondrial-derived ceramide or its metabolites ([@R24]). Ceramide is a precursor of SPH, which can subsequently be enzymatically converted into the bioactive lipid second messenger S1P by sphingosine kinase. To investigate the role of sphingosine kinase in the UPR^mt^, we examined the effects of sphk-1/sphingosine kinase mutants on UPR^mt^ activation in response to paraquat treatment. Paraquat disrupts ETC function at the inner mitochondrial membrane, leading to activation of the UPR^mt^ in mammalian cells, and in *C. elegans* ([@R10]; [@R31]; [@R41]). We examined UPR^mt^ activation by quantifying intestinal fluorescence of transgenic animals expressing enhanced GFP (eGFP) under the control of the *hsp-6* promoter (P*hsp-6::GFP*) ([@R24]; [@R41]). The *sphk-1(ok1097)* mutation deletes nearly the entire coding region of *sphk-1* and is predicted to eliminate SPHK-1 activity ([@R7]). In the absence of stress, P*hsp-6::GFP* expression was slightly but significantly reduced in *sphk-1* mutants compared to wild-type controls ([Figure 1A](#F1){ref-type="fig"}). However, the paraquat-induced increase in P*hsp-6::GFP* expression was reduced by 88% in *sphk-1* mutants, from 28-fold to 3.6-fold ([Figure 1A](#F1){ref-type="fig"}). The paraquat-induced increase in the expression of a second UPR^mt^ reporter, P*hsp60::GFP*, was completely blocked in *sphk-1* mutants ([Figure 1B](#F1){ref-type="fig"}; [@R31]; [@R41]). The defects in UPR^mt^ activation in *sphk-1* mutants were similar to those seen when atfs-1 was knocked down by RNAi ([Figure 1A](#F1){ref-type="fig"}; [@R16]). Knockdown of sphk-1 by RNAi or by the independently isolated *sphk-1(ju831)* missense mutation ([@R27]) attenuated paraquat-induced Phsp-6::GFP expression, albeit not as strongly as *sphk-1(ok1097)* mutations ([Figures S1A and S1B](#SD1){ref-type="supplementary-material"}). *sphk-1* mutations did not attenuate the activation of the SKN-1/Nrf2-mediated antioxidant response (P*gst-4::GFP* reporter induction; [Figure S1C](#SD1){ref-type="supplementary-material"}) ([@R18]) or the endoplasmic reticulum UPR (UPR^er^, P*hsp-4::GFP* reporter induction; [Figure S1D](#SD1){ref-type="supplementary-material"}) ([@R12]). These results indicate that *sphk-1* mutants have specific defects in UPR^mt^ activation.

SPHK-1 is expressed broadly in multiple tissues, including the nervous system, where it functions to promote neurotransmitter release, and the intestine, where its function is unknown ([@R7]; [@R6]). To identify the tissue(s) in which SPHK-1 functions to activate the UPR^mt^, we introduced transgenes containing *sphk-1* cDNA driven by either a neuron-specific promoter, *rab-3*, or an intestine-specific promoter, *ges-1*, into *sphk-1* mutants expressing P*hsp-6::GFP*. Intestinal *sphk-1* cDNA expression completely restored the paraquat-induced P*hsp-6::GFP* induction to wild-type levels in *sphk-1* mutants, whereas pan-neuronal *sphk-1* cDNA expression failed to elicit paraquat-induced P*hsp-6::GFP* induction in *sphk-1* mutants ([Figure 1C](#F1){ref-type="fig"}). Therefore, SPHK-1 functions cell autonomously in the intestine to activate the UPR^mt^.

To determine whether SPHK-1 activity is sufficient to activate the UPR^mt^, we selectively overexpressed SPHK-1 in the intestine. We observed a 1.6-fold increase in P*hsp-6::GFP* expression in animals overexpressing SPHK-1 in the intestine and a 2.3-fold increase in *sphk-1* mutants overexpressing SPHK-1 in the intestine but lacking SPHK-1 in all other tissues ([Figure 1D](#F1){ref-type="fig"}). The increase in *hsp-6* expression associated with SPHK-1 overexpression was dependent on *atfs-1*, but not on *dve-1*, *haf-1*, or *met-2* ([Figure S1E](#SD1){ref-type="supplementary-material"}). Thus, loss of intestinal SPHK-1 signaling blocks stress-induced UPR^mt^ activation, whereas restricted overexpression of SPHK-1 only in the intestine is sufficient to induce the UPR^mt^.

The impaired stress-induced UPR^mt^ activation of sphk-1 mutants could be explained by either defective UPR^mt^ activation in response to stress or general defects in mitochondrial stress sensing. To distinguish between these possibilities, we examined survival in the presence of paraquat ([@R19]). *sphk-1* mutants displayed significantly increased sensitivity to paraquat-induced toxicity compared to wild-type controls, and expression of SPHK-1 in the intestine fully restored normal paraquat sensitivity to *sphk-1* mutants ([Figure 1E](#F1){ref-type="fig"}). These results point to a role for SPHK-1 in conferring organism-wide protection to stress by specifically promoting the activation of the UPR^mt^ in the intestine.

SPHK-1 Promotes UPR^mt^ Activation by Diverse Mitochondrial Stressors {#S4}
---------------------------------------------------------------------

A variety of different pharmacological and genetic manipulations activate the UPR^mt^, including RNAi-mediated knockdown of components of the electron transport chain (ETC) or treatment with the mitochondrial ETC stressor antimycin A ([@R24]; [@R41]). We found that RNAi knockdown of ETC components (*atp-2, nuo-1, gas-1, cyc-2.1, or cco-1*) resulted in a robust induction of P*hsp-6::GFP* expression that was significantly diminished but not eliminated in *sphk-1* mutants ([Figure 2A](#F2){ref-type="fig"}) and that acute antimycin A-induced *hsp-6* expression was nearly abolished in *sphk-1* mutants ([Figure 2B](#F2){ref-type="fig"}). *phb-1*/prohibitin1 is an evolutionarily conserved mitochondrial protein that regulates mitochondrial biogenesis and morphology and stabilizes the mitochondrial genome, and *phb-1* knockdown is a potent activator of the UPR^mt^ ([@R11]). The induction of P*hsp-6::GFP* expression by *phb-1* RNAi knockdown was significantly decreased in *sphk-1* mutants compared to wildtype controls ([Figure 2C](#F2){ref-type="fig"}). In addition, we found that the increased P*hsp-6::GFP* expression associated with RNAi knockdown of genes involved in mitochondrial protein import (timm-23/translocase), mitochondrial fission (*drp-1*/DRP), or mitochondrial fusion (*eat-3*/dynamin or *fzo-1*/mito-fusion) was dependent on SPHK-1. However, disruption of mitophagy genes (*dct-1 or pink-1/*PINK1) failed to induce P*hsp-6::GFP* expression ([Figure 2A](#F2){ref-type="fig"}). These results show that SPHK-1 contributes to UPR^mt^ activation in response to diverse mitochondrial stressors as well as alterations in mitochondrial morphology. Moreover, because neurons are largely refractory to gene knockdown by RNAi ([@R3]), the requirement of SPHK-1 in RNAi-induced UPR^mt^ activation suggests that SPHK-1 activates the UPR^mt^ in response to mitochondrial stress arising cell autonomously in the intestine.

SPHK-1 Localizes to Intestinal Mitochondria {#S5}
-------------------------------------------

To determine the mechanism by which SPHK-1 activates the UPR^mt^, we first examined the subcellular localization of SPHK-1 in the intestine. SPHK-1::GFP fusion proteins expressed in the intestine (using the intestine-specific *ges-1* promoter) were fully functional in rescuing the UPR^mt^ defects of *sphk-1* mutants ([Figure S1F](#SD1){ref-type="supplementary-material"}), indicating that the localization pattern of SPHK-1::GFP is likely to reflect that of endogenous SPHK-1. SPHK-1::GFP adopted a reticulated fluorescence pattern that extended throughout the cytoplasm and SPHK-1 was excluded from the nucleusand plasma membrane ([Figure 3A](#F3){ref-type="fig"}). Mammalian sphingosine kinases have been reported to associate primarily with two intracellular organelles: mitochondria and the endoplasmic reticulum (ER) ([@R14]; [@R50]). SPHK-1::GFP co-localized strongly with the outer mitochondrial membrane marker TOMM-20::mCherry ([@R33]) but did not co-localize with the ER marker C34B2.10/signal peptidase ([Figures 3A and 3B](#F3){ref-type="fig"}; [@R55]). Thus, SPHK-1 selectively associates with mitochondria in intestinal cells.

We examined whether SPHK-1 signaling affects mitochondrial morphology. We found no obvious changes in the distribution or abundance of TOMM-20::mCherry fluorescence in the intestine or in the muscles in *sphk-1* mutants compared to wild-type controls ([Figures S2A and S2B](#SD1){ref-type="supplementary-material"}), suggesting that mitochondrial mass and protein import were largely unaffected in *sphk-1* mutants. Overexpression of SPHK-1 led to no obvious defects in intestinal mitochondrial morphology but resulted in a donut-like mitochondrial pattern in muscles in which mitochondria appeared to be fragmented ([Figure S2C](#SD1){ref-type="supplementary-material"}). Mitochondrial fragmentation is indicative of excessive mitochondrial fission and is associated with UPR^mt^ activation ([@R22]; [@R35]). Thus, SPHK-1 associates with mitochondrial membranes, and SPHK-1 signaling may increase mitochondrial fragmentation (at least in the muscle), possibly by a mechanism that affects the balance of mitochondrial fusion/fission.

Mitochondrial SPHK-1 Is Required for UPR^mt^ Activation {#S6}
-------------------------------------------------------

To determine whether the mitochondrial association of SPHK-1 is important for UPR^mt^ activation, we examined the effects of disrupting mitochondrial SPHK-1::GFP on paraquat-induced P*hsp-6::GFP* expression. SPHK-1 contains a conserved calcium/calmodulin (CaM)-binding motif that promotes sphingosine kinase association with cellular membranes in response to agonists ([@R7]; [@R20]; [@R57]). Mutation of the CaM-binding site of mammalian SphK1 decreases its association with the plasma membrane without affecting its catalytic activity or folding ([@R44]). We generated an SPHK-1::GFP fusion protein harboring a mutated CaM motif (SPHK-1(▵CaM)::GFP; [Figure 3C](#F3){ref-type="fig"}) and found that it adopted a uniform localization pattern throughout the cytoplasm that was strikingly different from the mitochondrial localization pattern of wild-type SPHK-1::GFP, both in muscle and intestine (Figures [3D](#F3){ref-type="fig"} and [S2D](#SD1){ref-type="supplementary-material"}). Critically, SPHK-1(▵CaM) was unable to fully restore paraquat-induced P*hsp-6::GFP* expression to *sphk-1* mutants ([Figure 3E](#F3){ref-type="fig"}) or to induce P*hsp-6::GFP* expression above baseline levels in the absence of stress ([Figure 3F](#F3){ref-type="fig"}). These results indicate that mitochondrial localization of SPHK-1 is essential for stress-induced UPR^mt^ activation.

S1P Production by SPHK-1 Activates the UPR^mt^ {#S7}
----------------------------------------------

The *C*. *elegans* genome encodes several conserved enzymes that are predicted to be involved in sphingolipid biogenesis and metabolism ([Figures S3A and S3B](#SD1){ref-type="supplementary-material"}). We tested the effect of RNAi knockdown of each sphingolipid metabolism enzyme on paraquat-mediated P*hsp-6::GFP* induction. As expected, knockdown of *sptl-1*/serine palmitoyltransferase, required early in the S1P biosynthetic pathway, completely abolished paraquat-induced *hsp-6* expression, as previously reported ([Figure S3B](#SD1){ref-type="supplementary-material"}; [@R24]). F27E5.1/ceramidase catalyzes the biosynthesis of SPH from ceramide. RNAi knockdown of F27E5.1/ceramidase significantly decreased paraquat-induced P*hsp-6::GFP* expression ([Figure S3B](#SD1){ref-type="supplementary-material"}). *tag-38*/S1P lyase is predicted to convert S1P to hexadecenal and phosphoethanolamine. RNAi knockdown of *tag-38*/S1P lyase enhanced paraquat-induced P*hsp-6::GFP* expression ([Figure S3B](#SD1){ref-type="supplementary-material"}). Thus, mutations predicted to decrease S1P levels (*sptl-1, sphk-1*, or F27E5.1) attenuate UPR^mt^ activation, whereas mutations predicted to increase S1P levels (*tag-38*/S1P lyase) enhance the UPR^mt^.

We next generated a kinase-dead (KD) version of SPHK-1 by mutating conserved amino acids in the catalytic domain that are critical for SphK catalytic activity ([Figure 3C](#F3){ref-type="fig"}; [@R37]). We found that SPHK-1(KD)::GFP localized to mitochondria ([Figure 3D](#F3){ref-type="fig"}), yet failed to fully restore paraquat-induced P*hsp-6::GFP* expression to *sphk-1* mutants ([Figure 3E](#F3){ref-type="fig"}) or to induce Phsp-6::GFP expression in the absence of stress ([Figure 3F](#F3){ref-type="fig"}). These findings are consistent with the notion that S1P may function as a sphingolipid metabolite that activates the UPR^mt^.

Mitochondrial SPHK-1 Abundance Is Stress Regulated {#S8}
--------------------------------------------------

Sphingosine kinase activity is primarily controlled by its regulated targeting to cellular membranes from cytosolic pools ([@R1]; [@R49]). We examined whether the mitochondrial abundance of SPHK-1::GFP is regulated by mitochondrial stress. Paraquat treatment for 24 hr produced a significant increase in the ratio of mitochondrial-to-cytosolic SPHK-1::GFP fluorescence compared to untreated controls, as well as an increase in the number of intestinal cells in which the mitochondrial SPHK-1::GFP pattern was detected (referred to as mitochondrial occupancy; Figures [4A](#F4){ref-type="fig"}, [4B](#F4){ref-type="fig"}, and [S4A](#SD1){ref-type="supplementary-material"}). The increase in the mitochondrial-to-cytosolic fluorescence ratio was driven by a large (2-fold) increase in mitochondrial SPHK-1::GFP fluorescence, accompanied by a significantly smaller increase in cytosolic fluorescence. Paraquat does not affect expression levels of the s*phk-1::gfp* transgene or the mitochondrial mass because paraquat treatment had no effect on the mitochondrial fluorescence intensity of TOMM-20::mCherry, which was expressed using the same intestinal promoter (ges-1) as the s*phk-1::gfp* transgenes ([Figure 4C](#F4){ref-type="fig"}). Consistent with this observation, prior transcriptome profiling studies found no evidence that *sphk-1* expression is stress regulated ([@R30]; [@R53]). Chronic activation of the UPR^mt^ by phb-1 or ETC gene knockdown also resulted in significantly increased SPHK-1::GFP mitochondrial abundance, without increasing mitochondrial mass (with the exception of nuo-1 RNAi; [Figures S4B--S4F](#SD1){ref-type="supplementary-material"}). Arsenite, a mitochondrial toxin that activates the mitochondrial antioxidant response but not the UPR^mt^, did not increase SPHK-1::GFP mitochondrial fluorescence ([Figures S1C, S4G, and S4H](#SD1){ref-type="supplementary-material"}), suggesting that mitochondrial SPHK-1 abundance is specifically regulated by stressors that activate the UPR^mt^. Finally, we found that paraquat treatment had no effect on mitochondrial SPHK-1::GFP abundance in muscles ([Figure S5A](#SD1){ref-type="supplementary-material"}). We conclude that mitochondrial association of SPHK-1 is positively regulated by multiple stressors that activate the UPR^mt^ and that the regulation of mitochondrial SPHK-1 abundance occurs in a stress- and tissue-specific manner. The increase in the ratio of mitochondrial-to-cytoplasmic SPHK-1::GFP abundance is consistent with the idea that stress regulates the recruitment of SPHK-1 to mitochondria from cytoplasmic pools.

Stress-Induced SPHK-1 Mitochondrial Association Precedes UPR^mt^ and Is Reversible {#S9}
----------------------------------------------------------------------------------

To explore the kinetics of SPHK-1 mitochondrial association during the UPR^mt^, we first examined mitochondrial SPHK-1::GFP association immediately following paraquat treatment for various periods. We detected a significant increase in SPHK1::GFP mitochondrial fluorescence after just 1 hr of paraquat treatment ([Figure 5A](#F5){ref-type="fig"}). SPHK-1::GFP fluorescence increased further after longer paraquat exposure and reached a maximum of \>2-fold after 24 hr of treatment. In contrast, P*hsp-6::GFP* induction was not detected until 4 hr of treatment and continued to increase until 24 hr of treatment ([Figure 5A](#F5){ref-type="fig"}). The increase in mitochondrial SPHK-1::GFP fluorescence seen after 1 hr was not due to an increase in mitochondrial mass or transgene expression ([Figure S5B](#SD1){ref-type="supplementary-material"}).

To determine whether the paraquat-induced increase in SPHK-1::GFP mitochondria abundance is reversible, we examined how long it would take for mitochondrial SPHK-1::GFP to return to baseline levels following paraquat removal. We found that the mitochondrial SPHK-1::GFP began to decline 7 hr after the removal of paraquat, returning to baseline by 17 hr. In contrast, P*hsp-6::GFP* induction continued to increase after paraquat removal ([Figure 5B](#F5){ref-type="fig"}). Thus, acute mitochondrial stress leads to the reversible association of SPHK-1 with mitochondria that occurs rapidly (within 1 hr) and begins to decline more slowly (within 4 hr) when stress is removed. In contrast, acute mitochondrial stress leads to a delayed transcriptional response beginning 4 hr after exposure that persists after stress removal for several hours, even after mitochondrial SPHK-1 levels return to baseline ([Figure 5C](#F5){ref-type="fig"}). These results support the idea that SPHK-1 association with mitochondria is stress regulated, reversible, and represents an early event in UPR^mt^ activation that likely occurs via rapid SPHK-1 mitochondrial translocation.

Neuroendocrine Signaling Regulates SPHK-1 Mitochondrial Abundance {#S10}
-----------------------------------------------------------------

To investigate the role of SPHK-1 in the cell non-autonomous activation of the UPR^mt^, we examined the effects of neuronal stress signaling on SPHK-1-mediated UPR^mt^ activation in the intestine. Prior studies have shown that EGL-3/pro-protein convertase (PC2), which processes neuropeptide precursors into mature peptides ([@R23]), and UNC-31/CAPS, which mediates calcium-dependent exocytosis of neuropeptide- and biogenic amine-containing dense-core vesicles (DCVs) ([@R47]), promote stress-induced activation of the UPR^mt^ ([@R4]; [@R43]). In agreement with these studies, we found that *egl-3* and *unc-31* null mutants reduced but did not eliminate UPR^mt^ activation in response to paraquat ([Figure S5C](#SD1){ref-type="supplementary-material"}). UNC-13 is a vesicle-priming factor that mediates the exocytosis of synaptic vesicles and DCVs from the nervous system ([@R39]; [@R45]). We found that unc-13 mutants also attenuated the paraquat-induced UPR^mt^ activation to an extent similar to that of *egl-3* mutants ([Figure S5C](#SD1){ref-type="supplementary-material"}), reinforcing the notion that neuropeptide and/or neurotransmitter release from neurons is required for paraquat-induced UPR^mt^ activation in the intestine.

To identify the neuronal-derived signals that regulate SPHK-1 signaling in the intestine, we examined SPHK-1::GFP mitochondrial abundance following paraquat treatment in *egl-3, unc-31,* and *unc-13* mutants. SPHK-1::GFP mitochondrial fluorescence was not detectably altered in these mutants in the absence of paraquat ([Figure 6A](#F6){ref-type="fig"}). However, the paraquat-induced increase in mitochondrial SPHK-1::GFP abundance was completely blocked in egl-3 mutants and was significantly attenuated in *unc-13* and *unc-31* mutants ([Figure 6A](#F6){ref-type="fig"}). In contrast, blocking serotonin biosynthesis using the *tph-1*/tryptophan hydroxylase mutant, which impairs UPR^mt^ activation ([@R4]), had no effect on stress-induced SPHK-1::GFP mitochondrial targeting ([Figure 6B](#F6){ref-type="fig"}). We conclude that neuropeptides, but not serotonin, activate the UPR^mt^ cell non-autonomously by positively regulating SPHK-1 mitochondrial association in the intestine.

To directly assess whether SPHK-1 promotes intestinal UPR^mt^ activation in response to neuronal mitochondrial stress, we examined UPR^mt^ activation elicited by neuronal-specific knockdown of *spg-7*/paraplegin. Pan-neuronal knockdown of *spg-7* using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease (Cas9) elicits robust UPR^mt^ activation in the intestine that is dependent upon *egl-3*/PC2 ([@R43]). We found that the increase in P*hsp-6::GFP* expression by neuronal *spg-7* knockdown was significantly reduced in *sphk-1* mutants, and that this defect was rescued to wild-type levels by intestine-specific expression of SPHK-1 ([Figure 6C](#F6){ref-type="fig"}). Furthermore, pan-neuronal *spg-7* knockdown increased mitochondrial SPHK-1::GFP abundance to an extent similar to that of paraquat treatment ([Figure 6D](#F6){ref-type="fig"}). Collectively, these results indicate that intestinal SPHK-1 is essential for cell non-autonomous UPR^mt^ activation by the nervous system and that neuropeptide release promotes SPHK-1 mitochondrial association in the intestine.

DISCUSSION {#S11}
==========

This study supports a model whereby SPHK-1 functions as part of an integrated organism-wide response to mitochondrial stress originating either cell autonomously in the intestine or cell nonautonomously in the nervous system that leads to the activation of the UPR^mt^ in the intestine. Cell non-autonomous SPHK-1 regulation occurs through the release of neuropeptides that promote SPHK-1 mitochondrial recruitment in the intestine, presumably through intestinal G protein-coupled receptor (GPCR) signaling. We propose that the rapid association of SPHK-1 with intestinal mitochondria in response to stress leads to the production of S1P from SPH, followed by the subsequent regulation of UPR^mt^ gene expression ([Figure 6E](#F6){ref-type="fig"}).

SPHK-1 Activates the UPR^mt^ {#S12}
----------------------------

Our results suggest that the strong defects of UPR^mt^ activation in *sphk-1* null mutants are not the result of general defects in mitochondrial function or in stress sensing, but rather are due to specific defects in stress-induced initiation of the UPR^mt^. First, mutants with impaired mitochondrial function (e.g., ETC mutants) are slow growing ([@R38]), whereas *sphk-1* mutants display largely normal rates of development ([@R8]). Second, mitochondrial abundance, morphology, and protein import do not appear to be grossly altered in *sphk-1* mutants ([Figures S2A and S2B](#SD1){ref-type="supplementary-material"}), and mitochondrial responses to oxidative stress in the intestine are indistinguishable from wild-type responses ([Figure S1C](#SD1){ref-type="supplementary-material"}). Finally, *sphk-1* mutants have normal rates of survival following mitochondrial stress induced by anoxia ([@R29]), yet are hypersensitive to paraquat-induced toxicity. Overexpressing SPHK-1 increases *hsp-6* expression by 2-fold, but it does not confer detectible resistance on paraquatinduced toxicity ([Figure 1E](#F1){ref-type="fig"}), suggesting that the UPR^mt^ transcriptional response may have to reach a certain threshold to promote organism-wide survival. *sphk-1* mutants have shorter lifespans than wild-type controls ([@R8]), a phenotype that is associated with impaired UPR^mt^ activation ([@R42]); but whether the UPR^mt^ defects cause shortened lifespans in *sphk-1* mutants remains to be determined. We also found that UPR^er^ activation seems to be significantly enhanced in sphk-1 mutants ([Figure S1D](#SD1){ref-type="supplementary-material"}), suggesting either an additional inhibitory role of SPHK-1 in UPR^er^ activation or the existence of SPHK-1-mediated crosstalk between the UPR^mt^ and the UPR^er^.

Our genetic analysis of SPHK-1 reveals that *sphk-1(ok1097)* null mutants attenuate UPR^mt^ activation to a significantly greater degree than *sphk-1(ju831)* mutants. The *sphk-1(ju831)* mutant encodes a P177S substitution located adjacent to the nucleotide binding site in the SPHK-1 kinase domain at a residue that is conserved between *C. elegans* and mammals but is not conserved in budding yeast ([@R37]). Thus, we speculate that residual kinase activity in this strain may account for the weaker UPR^mt^ defects seen in *sphk-1(ju831)* mutants compared to *sphk-1* null mutants ([@R27]). Nonetheless, we observed full rescue of *sphk-1(ok1097)* with two independent SPHK-1 transgenes (Figures [1C](#F1){ref-type="fig"} and [S1F](#SD1){ref-type="supplementary-material"}), providing strong support for the conclusion that SPHK-1 activates the UPR^mt^. RNAi-mediated knockdown of *sphk-1* was only effective in attenuating the UPR^mt^ in the F1 generation ([Figure S1A](#SD1){ref-type="supplementary-material"}), suggesting that low levels of SPHK-1 or SPHK-1 metabolites (provided maternally or embryonically) are sufficient to activate the UPR^mt^ in adults. The lack of effect on UPR^mt^ revealed by using RNAi in the parental (P0) generation may explain why *sphk-1* was not identified in previous large-scale RNAi screens for UPR^mt^ activators ([@R15]; [@R24]; [@R41]).

Mitochondrial SPHK-1 Activates the UPR^mt^ {#S13}
------------------------------------------

Several results support the idea that SPHK-1 association with mitochondrial membranes is an early event in UPR^mt^ activation. First, SPHK-1 association with intestinal mitochondria is stress dependent, and disruption of SPHK-1 mitochondrial localization (in SPHK-1\[DCaM\] mutants) strongly attenuates stress-induced UPR^mt^ activation. Second, selective overexpression of SPHK-1 is sufficient to activate the UPR^mt^ in an atfs-1-dependent manner in the absence of stress. Third, SPHK-1 mitochondrial association is dynamic; its abundance increases in response to mitochondrial stress and decreases when stressors are removed or when UPR^mt^ activation is compromised in neuroendocrine signaling mutants. Our kinetic analysis indicates that stressinduced association of SPHK-1 with mitochondria precedes the UPR^mt^ transcriptional response and that the UPR^mt^ transcription remains intact even after SPHK-1 dissociates from mitochondria. We suggest that stress-induced SPHK-1 translocation to mitochondria from cytoplasmic pools and subsequent S1P production is a mechanism by which the UPR^mt^ can be rapidly activated and sustained even if mitochondrial insults are transient.

Our results show that paraquat treatment increases the ratio of mitochondrial-to-cytoplasmic SPHK-1::GFP, which is consistent with the idea that stress promotes the targeting of SPHK-1 to mitochondria from the cytoplasm. We were surprised to find that paraquat treatment results in a small increase in cytoplasmic SPHK-1::GFP fluorescence instead of a decrease, as would be expected if SPHK-1 translocated to the mitochondria. We speculate that light scatter from SPHK-1::GFP associated with neighboring and out-of-plane mitochondria is likely to contribute to the inter-mitochondrial fluorescent signal. Our fluorescence imaging and ultrastructural studies show that mitochondria are very closely spaced throughout the intestine, with the majority being no more than 1 mm apart ([Figure 4](#F4){ref-type="fig"}; [@R56]). As a consequence, the increased SPHK-1::GFP abundance on mitochondria following paraquat treatment could lead to increased inter-mitochondrial fluorescence, even if cytosolic SPHK1::GFP abundance decreases.

Regulation of the translocation of sphingosine kinase to cellular membranes is the primary mechanism by which sphingosine kinase is activated. Muscarinic agonist treatment of HEK293 cells results in a rapid, reversible recruitment of approximately half of the SphK1 from the cytosol to the plasma membrane, with a half-time of 3--5 s ([@R52]). Sphingosine kinase membrane recruitment is mediated by both direct interaction of SphK with lipids on membranes (e.g., phosphatidic acid) and interaction of SphK with specific proteins ([@R46]). Notably, calcium and integrinbinding protein-1 (CIB1) has been shown to interact directly with the CaM domain of SphK1 in a calcium-dependent manner, and this interaction is important for SphK1 recruitment to the plasma membrane and S1P production ([@R20]). There are four CIB1 homologs in the C. elegans genome, including CALM-1, which regulates SPHK-1 targeting to synapses in motor neurons ([@R6]). RNAi knockdown of the intestinal gap-junction protein inx-17 or the inositol phosphate receptor itr-1 attenuates stress-induced UPR^mt^ activation ([@R24]), suggesting a role for calcium dynamics in regulating the UPR^mt^. Given the importance of the CaM domain in both SPHK-1 mitochondrial targeting and UPR^mt^ activation by SPHK-1, it will be interesting to determine whether calcium promotes UPR^mt^ activation by regulating SPHK-1 targeting to mitochondria.

S1P Signaling in the UPR^mt^ {#S14}
----------------------------

The 2014 study by Liu et al. showed that ceramide or its metabolites are involved in UPR^mt^ activation. The observation that knocking out ceramide synthase has minimal effects on UPR^mt^ activation ([Figure S3](#SD1){ref-type="supplementary-material"}; [@R24]), and our results showing that knockdown of multiple enzymes directly involved in S1P metabolism are able to alter UPR^mt^ activation lead us to favor the idea that ceramide metabolites (SPH or S1P) may be more important for UPR^mt^ activation than ceramide itself. It is also possible that ceramide and S1P may function cooperatively to activate the UPR^mt^. *C. elegans* encodes three ceramide synthase genes (*hyl-1, hyl-2*, and *lagr-1*), but RNAi knockdown of these genes alone did not alter paraquat-induced UPR^mt^ activation ([Figure S3](#SD1){ref-type="supplementary-material"}), suggesting that they may function redundantly to convert ceramide to SPH in the intestine. Consistent with this idea, HYL-1 and HYL-2 are both expressed in the intestine ([@R17]; [@R29]).

How might a small (2-fold) and transient increase in SPHK-1 mitochondrial association lead to a relatively large (\>20-fold) and prolonged transcriptional response? We speculate that small increases in SPHK-1 abundance could lead to relatively large increases in S1P through the enzymatic conversion of SPH to S1P on mitochondrial membranes. S1P, in turn, could generate long-lasting effects on the UPR^mt^ by stably associating with cellular targets, leading to enhanced transcriptional response by as-yet-undetermined mechanisms. S1P can act extracellularly as a secreted signaling messenger or as an intracellular signaling molecule. As a secreted signal, S1P signals via a family of five S1PR/EDG GPCRs ([@R40]). As an intracellular signal, S1P can directly associate with and modulate the activities of cytoplasmic proteins, including the E3 ubiquitin ligase TRAF2, histone deacetylases (HDAC1 and HDAC2), the mitochondrial mitophagy protein prohibitin ([@R2]; [@R13]; [@R54]), and members of the HSP-90 family of heat shock proteins ([@R34]). *C. elegans* does not encode obvious S1P receptors, so if secreted, S1P is likely to act by a mechanism that is independent of known S1P receptors. We favor the idea that S1P acts as intracellular signaling molecule that binds an as-yet-undefined intestinal target to activate the UPR^mt^. S1P generated by mitochondrial SphK2 interacts with prohibitin2 in the mitochondria to modulate the assembly and function of cytochrome oxidase, a component of the ETC, and mice lacking SphK2 function display defects in mitochondria respiration ([@R50]). Our results show that UPR^mt^ activation by *phb-1*/prohibitin knockdown is dependent on sphk-1 ([Figure 2C](#F2){ref-type="fig"}), suggesting that SPHK-1/S1P may not activate PHB-1 but instead function downstream of PHB-1 to activate the UPR^mt^. S1P signaling also plays an important role in the innate immune response in epithelial cells in response to ER stress by binding directly to the heat shock proteins GRP94 and HSP90a, resulting in the assembly of a transcriptional complex that activates innate immune response transcriptional targets ([@R34]). Based on these studies, it is tempting to speculate that S1P production may orchestrate the assembly of protein complexes in the mitochondria or cytoplasm that initiates UPR^mt^ activation.

STAR+METHODS {#S15}
============

KEY RESOURCES TABLE {#S16}
-------------------

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  REAGENT or RESOURCE                                                                                                                  SOURCE                           IDENTIFIER
  ------------------------------------------------------------------------------------------------------------------------------------ -------------------------------- ----------------------------------------------------------
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                         

  Methyl Viologen Hydrate (paraquat)                                                                                                   Fisher                           CAS:1910--42-5

  Tunicamycin                                                                                                                          Sigma-Aldrich                    CAS:11089--65-9

  Antimycin A                                                                                                                          Sigma-Aldrich                    CAS:1397--94-0

  Sodium Arsenite                                                                                                                      Ricca                            CAS:7140--16

  Experimental Models: Organisms/Strains                                                                                                                                

  *C. elegans:* N2                                                                                                                     Caenorhabditis Genetics Center   WB Cat\# N2\_(ancestral), RRID:WB-STRAIN:N2\_(ancestral)

  *C. elegans: sphk-1(ok1097)*                                                                                                         Caenorhabditis Genetics Center   WB Cat\# VC916, RRID:WB-STRAIN: VC916

  *C. elegans: hyl-1(gk203)*                                                                                                           Caenorhabditis Genetics Center   WB Cat\# VC334, RRID:WB-STRAIN: VC334

  *C. elegans: egl-3(nr2090)*                                                                                                          Caenorhabditis Genetics Center   WormBase: WBVar00091400 (RRID N/A)

  *C. elegans: unc-13(s69)*                                                                                                            Caenorhabditis Genetics Center   WB Cat\# BC168, RRID:WB-STRAIN: BC168

  *C. elegans: unc-31(e928)*                                                                                                           Caenorhabditis Genetics Center   WB Cat\# DA509, RRID:WB-STRAIN: DA509

  *C. elegans: tph-1(mg280)*                                                                                                           Caenorhabditis Genetics Center   WB Cat\# MT15434, RRID:WB-STRAIN: MT15434

  *C. elegans: SJ4100: zcIs13\[Phsp-6::GFP\]*                                                                                          Caenorhabditis Genetics Center   WB Cat\# SJ4100, RRID:WB-STRAIN: SJ4100

  *C. elegans: SJ4005: zcIs4\[Phsp-4::GFP\]*                                                                                           Caenorhabditis Genetics Center   WB Cat\# SJ4005, RRID:WB-STRAIN: SJ4005

  *C. elegans: SJ4058: zcIs9 \[Phsp-60::GFP + lin-15(+)\]*                                                                             Caenorhabditis Genetics Center   WB Cat\# SJ4058, RRID:WB-STRAIN: SJ4058

  *C. elegans: OJ4113: vjIs138\[Pges-1::sphk-1::gfp\]*                                                                                 This paper                       N/A

  *C. elegans: OJ4143: vjIs148\[Pges-1::tomm-20::mCherry\]*                                                                            This paper                       N/A

  *C. elegans: OJ2329: vjIs208\[Pgst-4::gfp\]*                                                                                         This paper                       Sean Curran

  *C. elegans: OJ1674: vjIs84\[Pmyo-3::invom::rfp\]*                                                                                   ([@R48])                         N/A

  *C. elegans: OJ4647: sphk-1(ok1097);zcIs4*                                                                                           This paper                       N/A

  *C. elegans: OJ4433: sphk-1(ok1097);zcIs9*                                                                                           This paper                       N/A

  *C. elegans: OJ4127: sphk-1(ok1097);vjEx920\[Pges-1::*\                                                                              This paper                       N/A
  *sphk-1::gfp\];zcIs13*                                                                                                                                                

  *C. elegans: OJ4364: sphk-1(ok1097);vjEx1025\[Pges-1::*\                                                                             This paper                       N/A
  *sphk-1(DCaM)\]::gfp;zcIs13*                                                                                                                                          

  *C. elegans: OJ4367: sphk-1(ok1097);vjEx1459\[Prab-3::*\                                                                             This paper                       N/A
  *sphk-1::mCherry\];zcIs13*                                                                                                                                            

  *C. elegans: OJ4365: sphk-1(ok1097);vjEx1058\[Pges-1::*\                                                                             This paper                       N/A
  *sphk-1(KD)\]::gfp zcIs13*                                                                                                                                            

  *C. elegans: OJ4139: sphk-1(ok1097);vjEx966\[Pges-1::*\                                                                              This paper                       N/A
  *sphk-1::mCherry\];zcIs13*                                                                                                                                            

  *C. elegans: OJ4648: sphk-1(ju831);zcIs13*                                                                                           This paper                       N/A

  *C. elegans: OJ4147: vjEx966\[Pges-1::sphk-1::mCherry\]; zcIs13*                                                                     This paper                       N/A

  *C. elegans: OJ4398: egl-3(nr2090);zcIs13*                                                                                           This paper                       N/A

  *C. elegans: OJ4397: unc-13(s96);zcIs13*                                                                                             This paper                       N/A

  *C. elegans: OJ4522: unc-31(e928);zcIs13*                                                                                            This paper                       N/A

  *C. elegans: OJ4265: hyl-1(gk203);zcIs13*                                                                                            This paper                       N/A

  *C. elegans: OJ4568: unc-31(e928);vjIs138\[Pges-1::sphk-1::gfp\]*                                                                    This paper                       N/A

  *C. elegans: OJ4569: unc-13(s69);vjIs138\[Pges-1::sphk-1::gfp\]*                                                                     This paper                       N/A

  *C. elegans: OJ4570: egl-3(nr2090);vjIs138\[Pges-1::sphk-1::gfp\]*                                                                   This paper                       N/A

  *C. elegans: OJ5015: tph-1(mg280);vjIs138\[Pges-1::sphk-1::gfp\]*                                                                    This paper                       N/A

  *C. elegans: OJ2582: vjEx1007\[Pges-1::tomm-20::gfp\]*                                                                               This paper                       N/A

  *C. elegans: OJ2835: vjEx1072\[Pmyo-3::sphk-1(KD)::gfp\]*                                                                            This paper                       N/A

  *C. elegans: OJ2577: vjEx1002\[Pmyo-3::sphk-1(DCaM)::gfp\]*                                                                          This paper                       N/A

  *C. elegans: OJ3331: vjEx1065\[Pges-1::tomm-20::mCherry\]*                                                                           This paper                       N/A

  *C. elegans: OJ2806: sphk-1(ok1097);vjEx1065\[Pges-1::tomm-*\                                                                        This paper                       N/A
  *20::mCherry\]*                                                                                                                                                       

  *C. elegans: OJ326: vjEx133\[Pmyo-3::sphk-1::gfp\]*                                                                                  ([@R6])                          N/A

  *C. elegans: LW96: \[Prab-3::Cas9+u69::spg-7-sg\];zcIs13*                                                                            ([@R43])                         N/A

  *C. elegans: OJ4751: sphk-1;zcIs13;\[Prab-3::Cas9+u69::spg-7-sg\]*                                                                   This paper                       N/A

  *C. elegans: OJ5095: sphk-1;vjEx966\[Pges-1::sphk-1::mCherry\];*\                                                                    This paper                       N/A
  *\[Prab-3::Cas9+u69::spg-7-sg\];zcIs13*                                                                                                                               

  *C. elegans: OJ4924: vjIs138\[Pges-1::sphk-1::gfp\];\[Prab-3::Cas9+ u69::spg-7-sg\]*                                                 This paper                       N/A

  *C. elegans: OJ1564: hjIs14\[Pvha-6::gfp::C34B2.10\]; vjEx1564*\                                                                     This paper                       N/A
  *\[Pges-1::sphk-1::mCherry\]*                                                                                                                                         

  Oligonucleotides                                                                                                                                                      

  For cloning *sphk-1* cDNA Forward:ccccccgctagcaaaaatgttcata gtagtggtaac Reverse:ccccccggtaccctaggcagttgatgagaaaacgg                  ([@R7])                          N/A

  Oligos used for quickchange PCR of *sphk-1*(*KD*) cDNA See the reference                                                             ([@R7])                          N/A

  Oligos used for quickchange PCR of sphk-1(▵CaM) cDNA See the reference                                                               ([@R7])                          N/A

  For cloning *tomm-20(n-terminus, 126bp)* cDNA Forward: ccccg ctagcaaaaatgtcgga cacaattcttgg Reverse: ccccaccggttccagcctgggcacgtctc   This paper                       N/A

  For *phb-1* RNAi clone Forward: ccccccgcatgcaaaagcactttcaag gcgacagta Reverse:\                                                      This paper                       N/A
  ccccccgctagctttgattcgaaggttagtgt                                                                                                                                      

  Recombinant DNA                                                                                                                                                       

  *pSK9\[Pges-1::sphk-1::gfp\]*                                                                                                        This paper                       N/A

  *pSK21\[Pges-1::sphk-1::mCherry\]*                                                                                                   This paper                       N/A

  *pSK70\[Prab-3::sphk-1::mCherry\]*                                                                                                   This paper                       N/A

  *pSK24\[Pges-1::tomm-20::gfp\]*                                                                                                      This paper                       N/A

  *pSK26\[Pges-1::tomm-20::mCherry\]*                                                                                                  This paper                       N/A

  *pSK28\[Pges-1::sphk-1(DCaM)::gfp\]*                                                                                                 This paper                       N/A

  *pSK29\[Pges-1::sphk 1(KD)::gfp\]*                                                                                                   This paper                       N/A

  *pSK27\[Pmyo-3::sphk 1(KD)::gfp\]*                                                                                                   This paper                       N/A

  *pSK25\[Pmyo-3::sphk 1(▵CaM)::gfp\]*                                                                                                 This paper                       N/A

  *pSK30\[L4440-phb-1\]*                                                                                                               This paper                       N/A

  Other                                                                                                                                                                 

  Sequence, gene information                                                                                                           N/A                              <https://wormbase.org/#012-34-5>
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CONTACT FOR REAGENT AND RESOURCE SHARING {#S17}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Derek Sieburth (<sieburth@usc.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S18}
--------------------------------------

### *C. elegans* strains and maintenance {#S19}

Strains used in this study were maintained at 20C on NGM plates following standard methods ([@R5]). As a food source, HB101 E.coli bacteria was used because sphk-1 mutants are developmentally healthier than when grown on OP50 E.coli bacteria ([@R8]). The wild-type reference strain was N2 Bristol. L4 or young adult hermaphrodites were used for all experiments. The following strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources: sphk-1(ok1097), hyl-1(gk203), egl-3(nr2090), unc-13(s69), unc-31(e928), tph-1(mg280). All strains used were outcrossed at least five times with wild-type prior to analysis. The strain information is at <https://wormbase.org/#012-34-5>.

METHOD DETAILS {#S20}
--------------

### Molecular biology {#S21}

Genes used in this study were cloned from *C. elegans* wild-type cDNA then inserted into pPD49.26-based vectors using standard molecular biology techniques, unless otherwise indicated. The plasmids and oligos used in this study are listed in the KEY RESCOURCES TABLE. Sequence files of plasmids are available upon request.

### Transgenic lines {#S22}

Transgenic strains were generated by injecting expression constructs (10--25 ng/ul) and the co-injection marker; *pJQ70 \[Pofm1::mCherry, 40 ng/ul\], KP\#708\[Pttx-3::rfp, 40 ng/ul\] or KP\#1106 \[Pmyo-2::gfp, 10 ng/ul\]* into N2 or corresponding mutants. Microinjection was performed following standard techniques as previously described ([@R28]). At least three lines for each transgene were tested and a representative transgene was used for further experiments. The transgenic lines used in this study are listed in the KEY RESCOURCES TABLE.

### Microscopy analysis {#S23}

For all fluorescence microscopy analysis, young adult worms were immobilized by using 2,3-butanedione monoxime (BDM, 30 mg/ mL; Sigma) in M9 buffer then mounted on 2% agarose pads for imaging. Images were captured with the Nikon eclipse 90i microscope equipped with a Nikon PlanApo 40 × or 60× or 100× objective (NA = 1.4) and a PhotometricsCoolsnap ES2 or a Hamamatsu Orca Flash LT+ CMOS camera. To quantify the fluorescence intensity of P*hsp-6::GFP*, P*hsp-4::GFP*, and P*hsp-60::GFP* fluorescent reporters, intestinal cells posterior to the vulva were imaged due to low basal expression in the absence of stress. To analyze P*gst-4::GFP* expression, SPHK-1::GFP abundance, and TOMM-20::mCherry or GFP abundance, about 5μm diameter region in posterior intestinal cells were selected for fluorescence intensity quantification. To analyze mitochondrial SPHK-1::GFP and TOMM20::mCherry abundance, average fluoresce intensity from 0.1 mm diameter regions on individual mitochondria from at least 20 animals was measured. For cytosolic abundance, average fluorescence intensity of 0.1 mm diameter regions in intestinal cells between mitochondria was measured. The number of animals and mitochondria analyzed are listed in [Table S1](#SD2){ref-type="supplementary-material"}. For each experimental sample set, image acquisition was conducted in parallel on the same day. The maximum intensity projection of images was recorded using Metamorph 7.0 software (Universal Imaging/Molecular Devices). For mitochondrial occupancy analysis, only intestinal cells showing reticulated fluorescence pattern were counted. H (high), M (medium) L (low) indicates the percentage of animals showing mitochondrial localized-SPHK-1::GFP more than 2/3 of intestine (H), half of intestine (M), only in a few intestinal cells (L), respectively. For [Figure 3E and F](#F3){ref-type="fig"}, [Figure S1F](#SD1){ref-type="supplementary-material"}, the fluorescence intensity of SPHK-1::GFP, SPHK-1(▵CaM)::GFP and SPHK-1(KD)::GFP transgenes in intestine was approximately ten fold lower compared to *hsp-6::GFP* fluorescence, thus they did not significantly impact *hsp-6::GFP* intensity levels.

### RNA Interference {#S24}

Feeding RNAi knockdown assays were performed following established protocols ([@R21]). Briefly, gravid adult animals were placed on RNAi plates seeded with HT1115(DE3) bacteria transformed with L4440 vector containing the insert of the gene targeted for knockdown or empty L4440 vector as a control, and eggs were collected for 4 hours to obtain age-matched synchronized worm populations. Young adult animals were used for all RNAi assays. RNAi clones were from the Ahringer RNAi library ([@R21]) and *dct-1, drp-1, fis-1, pink-1, dve-1, haf-1, met-2, lagr-1, hyl-2, sptl-1, F27E5.1, T27F6.6, tag-38* were confirmed by sequencing.

### Stress induction assays {#S25}

For drug-induced stress, transgenic L4 animals were transferred to fresh NGM plates seeded with HB101 bacteria, then 80 mL of stock solutions of drugs was added to plates for a final concentration of 0.4 mM paraquat, 40 mM arsenite, 80nM Antimycin A. Drugs were dissolved in M9 buffer except Antimycin A, which was dissolved in DMSO. 24 hours later, adults were removed for fluorescence microscopy analysis. For paraquat treatment, 0.4 mM paraquat for 24 hours was used for most assays, unless otherwise indicated. These conditions produced the most significant induction of *hsp-6* expression with no toxicity but slightly delayed development. For the analysis of time course-expression of P*hsp-6::GFP* and SPHK-1::GFP ([Figure 5A](#F5){ref-type="fig"}), 19 to 45 L4 animals were placed on HB101 plates containing 0.4 mM paraquat, and were removed for imaging immediately after 1 hour, 4 hours, 10 hours or 24 hours exposure. For [Figure 5B](#F5){ref-type="fig"}, 22 to 26 L4 animals treated with 0.4 mM paraquat for 4 hours were transferred to new NGM plates without paraquat for 2.5 hours, 7 hours, 13 hours for recovery and then removed for imaging. To synchronize animals for imaging following RNAi treatment, L4 animals were transferred to fresh RNAi plates and imaged 24 hours later. For P*hsp-4::GFP* induction assays, L4 animals were transferred to seeded NGM plates containing 10mM tunicamycin and imaged 24 hours later. For P*gst-4::GFP* imaging, young adult animals are incubated with 5mM arsenite in liquid solution for 1 hour then arsenite was washed out and worms were transferred onto the new NGM plates for 4 hours before imaging. As a control, M9 buffer was used as a control for paraquat and arsenite treatment, and DMSO was used as a control for Antimycin A and tunicamycin treatment. Identifiers of drugs used in this study are listed in the Key Resources Table.

### Stress survival assays {#S26}

For paraquat survival assays ([Figure 1E](#F1){ref-type="fig"}), young adult animals were placed onto NGM plates containing 10mM paraquat for 17 hours. After 17 hours, the percentage of surviving animals was counted every 3 hours over the course of 15 hours. Survival assay were done in experimental duplicate for each biological duplicate. The number of animals tested are indicated in the [Table S1](#SD2){ref-type="supplementary-material"}.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S27}
---------------------------------------

For all assays, the Student's t test (two-tailed) was used to determine the statistical significance. P values less than 0.05, 0.01 or 0.001 are indicated with asterisks \* (p \< 0.05), \*\*(p \< 0.01), \*\*\*(p \< 0.001), respectively. Error bars in the figures indicate the standard error of the mean (±SEM). The exact sample sizes (n) and ± SEM values corresponding to all figures are listed in [Table S1](#SD2){ref-type="supplementary-material"}.

Supplementary Material {#SM1}
======================

We thank members of the lab for advice and critical review of the manuscript, and Sean Curran for the Pgst-4::GFP integrant. We thank Yishi Jin and Katherine McCulloch for providing the sphk-1(ju831) strain, Ying Liu for the LW96 strain and Ho Yi Mak for hjIs14. This work was supported by grants from the NIH National Institute of Neurological Disorders and Stroke (NINDS) to D.S. (NS071085 and NS099414). Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).

DECLARATION OF INTERESTS

The authors declare no competing interests.

SUPPLEMENTAL INFORMATION

Supplemental Information includes five figures and one table and can be found with this article online at <https://doi.org/10.1016/j.celrep.2018.08.037>.

![SPHK-1 Positively Regulates UPR^mt^ Activation\
(A) Representative images and fluorescence quantification of intestinal P*hsp-6*::GFP in young adult wild-type, wild-type in which *atfs-1* is knocked down by RNAi, and *sphk-1* mutants following treatment with M9 (control) or paraquat (PQ) for 24 hr.\
(B) Representative images and quantification of intestinal *Phsp-60*::*GFP* in the indicated strains following control or paraquat treatment.\
(C) Representative images and quantification of intestinal *Phsp-6*::*GFP* in the indicated strains following control or paraquat treatment. Intestinal rescue denotes *sphk-1* mutants expressing P*ges-1*::*sphk-1*::*mCherry* transgenes. Neuronal rescue denotes *sphk-1* mutants expressing P*rab-3*::*sphk-1*::*mCherry* transgenes.\
(D) Representative images and quantification of intestinal P*hsp-6::GFP* in indicated strains following control or paraquat treatment. Intestinal SPHK-1 denotes animals expressing P*ges-1::sphk-1::mCherry* transgenes.\
(E) Survival curves of indicated strains on plates containing 10 mM paraquat.\
Scale bar represents 10 mm. Error bars indicate ± SEMs. The sample sizes (n) and ± SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Student's t test; \*p \< 0.05, \*\*\*p \< 0.001, ns, nonsignificant. wt, wild-type.](nihms-1507854-f0002){#F1}

![SPHK-1 Activates the UPR^mt^ Induced by Diverse Mitochondrial Stressors\
(A) Representative images and quantification of intestinal P*hsp-6::GFP* in wild-type and sphk-1 mutants treated with paraquat, *atp-2, nuo-1, gas-1, cyc-2.1, cco-1* (ETC genes), *timm-23* (translocase), *drp-1, fis-1* (mito-fission), *eat-3, fzo-1* (mito-fusion), or dct-1, *pink-1* (mitophagy) RNAi.\
(B) Representative images and quantification of P*hsp-6::GFP* expression in wild-type or *sphk-1* mutants in the absence or presence of antimycin A in intestinal cells\
(C) Representative images and quantification of P*hsp-6::GFP* expression in wild-type or *sphk-1* mutant intestines treated with empty vector control (e.v.) or *phb-1*/ prohibitin1 RNAi.\
Scale bar represents 10 μm. Error bars indicate ± SEMs. The sample size (n) and ± SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Student's t test; \*\*\*p \< 0.001.](nihms-1507854-f0003){#F2}

![Mitochondrial Localization and Kinase Activity of SPHK-1 Are Essential for *sphk-1*-Mediated UPR^mt^ Activation\
(A) Co-localization of SPHK-1::GFP fusion proteins with the outer mitochondrial membrane marker TOMM-20::mCherry in the young adult intestines of *sphk-1* mutants. Asterisk indicates an intestinal nucleus (left). Cross-sectional fluorescence intensity graph of GFP and mCherry corresponding to the dotted line at left (right).\
(B) Co-localization of intestinal SPHK-1::mCherry fusion proteins with the ER marker GFP::C34B2.10. Asterisk indicates intestinal nucleus (left). Cross-sectionalfluorescence intensity graph of GFP and mCherry corresponding to the dotted line at left (right).\
(C) Predicted structure of SPHK-1 showing the kinase domain and calmodulin binding motif (CaM). C1--C5 denotes conserved domains found in human (H.s.) SphK1 and SphK2 proteins. Amino acid substitutions made to generate the kinase dead (KD) and ▵CaM SPHK-1 variants are underlined.\
(D) Representative images of sphk-1 mutants expressing SPHK-1::GFP, SPHK-1(▵CaM)::GFP, and SPHK-1(KD)::GFP in muscles.\
(E) Representative images and quantification of P*hsp-6::GFP* fluorescence in the indicated strains in the absence or presence of paraquat (for 24 hr). Rescue denotes *sphk-1* mutants expressing the indicated *sphk-1* cDNA transgenes under control of the intestinal ges-1 promoter.\
(F) Average fluorescence of intestinal P*hsp-6::GFP* expressed in the indicated strains in the absence of stress is quantified.\
The sample sizes (n) and ± SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Scale bar represents 10 μm. Error bars indicate ± SEMs. Student's t test; \*p \< 0.05, \*\*\*p \< 0.001.](nihms-1507854-f0004){#F3}

![Mitochondrial Stress Promotes Mitochondrial SPHK-1 Accumulation\
(A) Representative intestinal images of animals co-expressing SPHK-1::GFP and mito-marker TOMM-20::mCherry following 24-hr paraquat treatment. Scale barrepresents 10 μm. Asterisk indicates intestinal nucleus.\
(B) Representative images of intestinal SPHK-1::GFP in the absence or presence of paraquat. The yellow asterisk marks the reticulated region within the intestinal cells used to quantify mitochondrial SPHK-1::GFP abundance. The white asterisk marks the region in between mitochondria used to quantify cytosolic SPHK1::GFP abundance (left). Average GFP fluorescence intensity of mitochondrial or cytoplasmic SPHK-1::GFP is quantified (center). The ratio of mitochondrial-tocytosolic SPHK-1::GFP fluorescence is quantified (right). Scale bar indicates 2 mm.\
(C) Representative images and quantification of TOMM-20::mCherry in intestinal cells in the absence or presence of paraquat. See (B) for details. Scale barindicates 2 μm.\
The sample sizes (n) and ±SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Error bars indicate ± SEMs. Student's t test; p \< 0.001](nihms-1507854-f0005){#F4}

![Mitochondrial SPHK-1 Abundance Changes Rapidly in Response to Acute Stress\
(A) Representative images and quantification of intestinal P*hsp-6::GFP* and SPHK-1::GFP fluorescence in the intestines of animals treated with paraquat for 0, 1, 4, 10, or 24 hr.\
(B) Representative images and quantification of intestinal P*hsp-6::GFP* and SPHK-1::GFP fluorescence in the intestines of animals treated with paraquat for 4 hr following recovery for 0, 2.5, 7, or 13 hr.\
(C) Time course of average increases in the intensity of P*hsp-6::GFP* and SPHK-1::GFP normalized to maximum fluorescence intensity. Acute stress (4-hr paraquat treatment) leads to rapid increases in SPHK-1::GFP mitochondrial association that precede the UPR^mt^ transcriptional response. Removal of stress leads to a more gradual reduction in SPHK-1 mitochondrial association without reducing the UPR^mt^ transcriptional response.\
Error bars indicate ± SEMs. The sample size (n) and ± SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Scale bar represents 10 mm. Student's t test; \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.](nihms-1507854-f0006){#F5}

![Cell Non-autonomous UPR^mt^ Activation by Neuropeptide Signaling Requires *sphk-1* and Recruits SPHK-1 to Mitochondria\
(A) Representative images and quantification of the intestines of wild-type adults, *egl-3*/PC2, *unc-31*/CAPS, and *unc-13*/Munc13 mutants expressing SPHK1::GFP in the absence or presence of paraquat for 24 hr.\
(B) Representative images and quantification of the intestines of wild-type and *tph-1*/tryptophan hydroxylase mutant adults expressing intestinal SPHK-1::GFP in the absence or presence of paraquat for 24 hr.\
(C) Representative images and quantification of intestinal Phsp-6::GFP expression in wild-type or *sphk-1* mutants expressing *rab-3p::Cas9+u6p::spg-7-sg* transgenes in which neuronal specific UPR^mt^ is induced by neuronal *spg-7* knockdown. Intestinal rescue denotes animals carrying P*ges-1::sphk-1::mCherry* transgenes\
(D) Representative images and quantification of intestinal SPHK-1::GFP fluorescence in wild-type or in animals expressing the neuronal *spg-7* knockdown transgene (*rab-3p::Cas9+u6p::spg-7-sg*).\
(E) Working model for UPR^mt^ activation by SPHK-1. Mitochondrial stressors induce SPHK-1 translocation to mitochondrial membranes from the cytoplasm, where SPHK-1 catalyzes the production of S1P from SPH. S1P then activates the UPR^mt^ transcriptional response. Neuroendocrine signaling from the nervous system and cell autonomous mitochondrial stress activates the UPR^mt^ by regulating intestinal SPHK-1 abundance on mitochondria.\
Error bars indicate ± SEMs. The sample size (n) and ± SEMs are listed in [Table S1](#SD2){ref-type="supplementary-material"}. Scale bar represents 10 mm. Student's t test; \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.](nihms-1507854-f0007){#F6}

###### Highlights

-   SPHK-1/sphingosine kinase functions cell autonomously to activate the UPR^mt^

-   SPHK-1 is targeted to mitochondria in response to mitochondrial stress

-   SPHK-1 mitochondrial targeting is dynamic and occurs before UPR^mt^ activation

-   SPHK-1 mitochondrial association is positively regulated by neuroendocrine signaling
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